Cours Satsuma Pharmaceuticals, Inc.
Actions
STSA
US80405P1075
Recherche biotechnologique et médicale
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Ryoichi Nagata
CEO | Chief Executive Officer | 65 | 08/06/23 |
Mic Iwashima
COO | Chief Operating Officer | 46 | 01/01/17 |
Chief Tech/Sci/R&D Officer | 63 | 01/07/17 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Ryoichi Nagata
CEO | Chief Executive Officer | 65 | 08/06/23 |
Director/Board Member | 64 | 08/06/23 | |
Ken Takanashi
BRD | Director/Board Member | 59 | 01/06/16 |
Varia. 1 janv. | Capi. | |
---|---|---|
-0,49 % | 105 Md | |
+3,31 % | 97,5 Md | |
+1,66 % | 22,19 Md | |
-16,16 % | 21,33 Md | |
-6,82 % | 18,68 Md | |
-41,41 % | 16,6 Md | |
-22,87 % | 14,52 Md | |
+6,32 % | 14,09 Md | |
+21,46 % | 10,99 Md |